Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
8.31
-0.05 (-0.60%)
At close: Jan 9, 2026, 4:00 PM EST
8.29
-0.02 (-0.24%)
After-hours: Jan 9, 2026, 7:54 PM EST
CRBP Market Cap
CRBP has a market cap or net worth of $153.97 million as of January 9, 2026. Its market cap has decreased by -2.73% in one year.
Market Cap
153.97M
Enterprise Value
52.04M
1-Year Change
-2.73%
Ranking
Category
Stock Price
$8.31
Market Cap Chart
Since November 11, 2014, CRBP's market cap has increased from $75.80M to $153.97M, an increase of 103.13%. That is a compound annual growth rate of 6.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 146.70M | 2.66% |
| Dec 31, 2025 | 142.90M | -0.56% |
| Dec 31, 2024 | 143.70M | 438.20% |
| Dec 29, 2023 | 26.70M | 93.48% |
| Dec 30, 2022 | 13.80M | -82.10% |
| Dec 31, 2021 | 77.10M | -26.57% |
| Dec 31, 2020 | 105.00M | -70.26% |
| Dec 31, 2019 | 353.10M | 5.62% |
| Dec 31, 2018 | 334.30M | -14.19% |
| Dec 29, 2017 | 389.60M | 3.75% |
| Dec 30, 2016 | 375.50M | 505.65% |
| Dec 31, 2015 | 62.00M | -19.58% |
| Dec 31, 2014 | 77.10M | 1.72% |
| Nov 11, 2014 | 75.80M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 986.77B |
| Johnson & Johnson | 496.99B |
| AbbVie | 405.61B |
| UnitedHealth Group | 308.06B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.63B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |